Viridian Therapeutics Inc (VRDN)

10:00 AM

Viridian Therapeutics, Inc. (VRDN) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Nasdaq

10:00 AM

06:39 AM

Viridian submits BLA for veligrotug to treat TED - Eyes On Eyecare

06:39 AM

05:52 AM

Corton Capital Inc. Makes New Investment in Viridian Therapeutics, Inc. $VRDN - MarketBeat

05:52 AM

05:46 AM

VRDN: BTIG Reiterates 'Buy' Rating and Price Target at $61.00 | - GuruFocus

05:46 AM

03:40 AM

Chart based analysis of Viridian Therapeutics Inc. trendsQuarterly Trade Review & Consistent Income Trade Ideas - newser.com

03:40 AM

Nov 03, 2025

Smart tools for monitoring Viridian Therapeutics Inc.’s price action2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Viridian Therapeutics submits Biologics License Application to FDA for veligrotug - Ophthalmology Times

Nov 03, 2025

Nov 03, 2025

Viridian Therapeutics submits BLA for thyroid disease drug - Traders Union

Nov 03, 2025

Nov 03, 2025

Viridian Therapeutics (VRDN) Submits BLA for Veligrotug to FDA - GuruFocus

Nov 03, 2025

Nov 03, 2025

Trend analysis for Viridian Therapeutics Inc. this weekWeekly Risk Report & AI Forecast for Swing Trade Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Can Viridian Therapeutics Inc. stock attract ESG capital inflowsJuly 2025 Pullbacks & Daily Stock Momentum Reports - newser.com

Nov 03, 2025

Nov 03, 2025

Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease - The Joplin Globe

Nov 03, 2025

Nov 03, 2025

How hedge fund analytics apply to Viridian Therapeutics Inc. stockTrade Ideas & Weekly High Momentum Picks - newser.com

Nov 03, 2025

Nov 03, 2025

How Viridian Therapeutics Inc. stock reacts to job market dataQuarterly Portfolio Summary & Target Return Focused Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Can machine learning forecast Viridian Therapeutics Inc. recovery2025 Top Gainers & Weekly High Return Stock Forecasts - newser.com

Nov 03, 2025

Nov 02, 2025

How buybacks impact Viridian Therapeutics Inc. stock valueJuly 2025 Short Interest & Safe Capital Allocation Plans - newser.com

Nov 02, 2025

Nov 02, 2025

Can swing trading help recover from Viridian Therapeutics Inc. lossesShare Buyback & Community Consensus Trade Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Top chart patterns to watch in Viridian Therapeutics Inc.Rate Cut & High Win Rate Trade Tips - newser.com

Nov 02, 2025

Nov 02, 2025

Will Viridian Therapeutics Inc. (1S1) stock attract long term capital inflows2025 Key Lessons & Fast Exit and Entry Trade Guides - newser.com

Nov 02, 2025

Nov 02, 2025

Chart based exit strategy for Viridian Therapeutics Inc.2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com

Nov 02, 2025

Nov 02, 2025

Why Viridian Therapeutics Inc. (1S1) stock is a must watch tickerWeekly Stock Analysis & Verified Chart Pattern Signals - newser.com

Nov 02, 2025

Nov 01, 2025

Regression analysis insights on Viridian Therapeutics Inc. performanceDay Trade & Free Verified High Yield Trade Plans - newser.com

Nov 01, 2025

Nov 01, 2025

Is Viridian Therapeutics Inc. stock attractive for growth ETFsSell Signal & Community Consensus Trade Alerts - newser.com

Nov 01, 2025

Nov 01, 2025

Oppenheimer Maintains Viridian Therapeutics (VRDN) Outperform Recommendation - MSN

Nov 01, 2025

Nov 01, 2025

Moody Aldrich Partners LLC Has $1.25 Million Stake in Viridian Therapeutics, Inc. $VRDN - MarketBeat

Nov 01, 2025

Oct 31, 2025

Reassessing Viridian Therapeutics (VRDN) Valuation Following Insider Buying and Progress in Thyroid Eye Disease Program - Sahm

Oct 31, 2025

Oct 31, 2025

Astria, Viridian Therapeutics, and More Stocks See Action From Activist Investors - Barron's

Oct 31, 2025

Oct 31, 2025

Fairmount Funds Management LLC's Strategic Acquisition in Viridian Therapeutics Inc - GuruFocus

Oct 31, 2025

Oct 31, 2025

Wedbush Reduces Earnings Estimates for Viridian Therapeutics - MarketBeat

Oct 31, 2025

Oct 31, 2025

How supply chain issues affect Viridian Therapeutics Inc. stock2025 Top Decliners & Free High Return Stock Watch Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

How Viridian Therapeutics Inc. stock performs in interest rate cyclesEarnings Miss & Consistent Growth Stock Picks - newser.com

Oct 31, 2025

Oct 31, 2025

Is Viridian Therapeutics Inc. (1S1) stock a buy on weaknessTrade Volume Report & Real-Time Volume Surge Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Using Ichimoku Cloud for Viridian Therapeutics Inc. technicalsEarnings Overview Report & Short-Term High Return Ideas - newser.com

Oct 31, 2025